+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia

Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia

Journal of Infectious Diseases 192(11): 1898-1907

Recently, we described the discovery of a novel group 2 coronavirus, coronavirus HKU1 (CoV-HKU1), from a patient with pneumonia. However, the clinical and molecular epidemiological features of CoV-HKU1-associated pneumonia are unknown. Prospectively collected (during a 12-month period) nasopharyngeal aspirates (NPAs) from patients with community-acquired pneumonia from 4 hospitals were subjected to reverse-transcription polymerase chain reaction, for detection of CoV-HKU1. The epidemiological, clinical, and laboratory characteristics of patients with CoV-HKU1-associated pneumonia were analyzed. The pol, spike (S), and nucleocapsid (N) genes were also sequenced. NPAs from 10 (2.4%) of 418 patients with community-acquired pneumonia were found to be positive for CoV-HKU1. All 10 cases occurred in spring and winter. Nine of these patients were adults, and 4 had underlying diseases of the respiratory tract. In the 6 patients from whom serum samples were available, all had a 4-fold change in immunoglobulin (Ig) G titer and/or presence of IgM against CoV-HKU1. The 2 patients who died had significantly lower hemoglobin levels, monocyte counts, albumin levels, and oxygen saturation levels on admission and had more-extensive involvement visible on chest radiographs. Sequence analysis of the pol, S, and N genes revealed 2 genotypes of CoV-HKU1. CoV-HKU1 accounts for 2.4% of community-acquired pneumonia, with 2 genotypes in the study population. Without performance of diagnostic tests, the illness was clinically indistinguishable from other community-acquired pneumonia illnesses.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 011863867

Download citation: RISBibTeXText

PMID: 16267760

DOI: 10.1086/497151

Related references

Clinical features and molecular epidemiology of coronavirus-HKU1-associated community-acquired pneumonia. Hong Kong Medical Journal 15(Suppl. 9): 46-47, 2009

Molecular epidemiological and clinical features of coronavirus HKU1 in children with acute respiratory tract infection in Lanzhou. Zhonghua Er Ke Za Zhi 48(10): 744-747, 2010

Community and hospital-acquired bacterial pneumonia in HIV-infected patients Clinical and epidemiological features. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34: 243, 1994

In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putative cleavage site of coronavirus HKU1 3C-like protease. Microbiology and Immunology 49(10): 899-908, 2005

Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. Journal of Virology 80(14): 7136-7145, 2006

Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology 16(5): 856-861, 2011

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. Journal of Virology 79(2): 884-895, 2004

Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Archives of Virology 150(11): 2299-2311, 2005

Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia. Intensive Care Medicine 25(2): 198-206, 1999

Community-acquired pneumonia in casualty: etiology, clinical features, diagnosis, and management (or a look at the "new" in pneumonia since 2002). Current Opinion in Pulmonary Medicine 10(3): 166-170, 2004

Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax 66(3): 247-252, 2011

Two cases of severe obstructive pneumonia associated with an HKU1-like coronavirus. European Journal of Medical Research 12(3): 134-138, 2007

The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 133(3): 618-624, 2008

Clinical and epidemiological study of community-acquired pneumonia in children aged less than 5 years old. Anales de Pediatria 63(2): 131-136, 2005

A case-control study of community-acquired Acinetobacter baumannii pneumonia and melioidosis pneumonia in northeast Thailand: an emerging fatal disease with unique clinical features. Diagnostic Microbiology and Infectious Disease 87(1): 79-86, 2017